Apogee Engineering LLC,* Colorado Springs, Colorado (FA8075-25-D-0009); Joint Research and Development LLC,* Stafford, Virginia (FA8075-25-D-0010); KIHOMAC Inc ...
ARA landed a $111.5M Navy contract for research and development services for the Center for High Performance Computing.
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Coriolis Pharma, a globally operating contract research and development ...
Under this University Affiliated Research Center contract, the contractor shall provide personnel from academic disciplines required to accomplish the following core research and development ...
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc. (MNOV), a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange (Code ...
The Army doubles the pool of awardees for this new iteration of its Geospatial Research, Integration, Development and Support program. The Army has finalized its award of a five-year, $499 million ...
The National Institutes of Health has awarded the Alliance for Advancing Biomedical Research a potential 25-year, $89 billion recompete contract to manage and operate a federally funded research and ...
The Navy has awarded eight companies positions on a five-year, $243.9 million contract for research-and-development work focused on tactical combat and electronic warfare systems. Naval Research ...
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...
A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the ...
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...
SHANGHAI, Feb. 2, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license ...